Evidence map›Paper›PMID 41557947›Full record

ArticleJournal of chemical information and modeling2026

Ab-SELDON: Leveraging Diversity Data for an Efficient Automated Computational Pipeline for Antibody Design.

Jean V Sampaio, Andrielly H S Costa, Aline O Albuquerque, Júlia S Souza, Diego S Almeida, Eduardo M Gaieta, Matheus V Almeida, Geraldo R Sartori, João H M Silva

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jean V SampaioLaboratory of Structural and Functional Biology Applied to Biopharmaceuticals, Fundação Oswaldo Cruz, Fiocruz Ceará, Eusébio 61773-270, Brazil.ORCID 0009-0004-7717-5076
Andrielly H S CostaLaboratory of Structural and Functional Biology Applied to Biopharmaceuticals, Fundação Oswaldo Cruz, Fiocruz Ceará, Eusébio 61773-270, Brazil.ORCID 0000-0002-5871-8352
Aline O AlbuquerqueLaboratory of Structural and Functional Biology Applied to Biopharmaceuticals, Fundação Oswaldo Cruz, Fiocruz Ceará, Eusébio 61773-270, Brazil.ORCID 0000-0003-2072-157X
Júlia S SouzaLaboratory of Structural and Functional Biology Applied to Biopharmaceuticals, Fundação Oswaldo Cruz, Fiocruz Ceará, Eusébio 61773-270, Brazil.ORCID 0009-0002-5113-7595
Diego S AlmeidaLaboratory of Structural and Functional Biology Applied to Biopharmaceuticals, Fundação Oswaldo Cruz, Fiocruz Ceará, Eusébio 61773-270, Brazil.ORCID 0009-0006-5320-1596
Eduardo M GaietaLaboratory of Structural and Functional Biology Applied to Biopharmaceuticals, Fundação Oswaldo Cruz, Fiocruz Ceará, Eusébio 61773-270, Brazil.ORCID 0000-0001-7954-5326
Matheus V AlmeidaLaboratory of Structural and Functional Biology Applied to Biopharmaceuticals, Fundação Oswaldo Cruz, Fiocruz Ceará, Eusébio 61773-270, Brazil.ORCID 0000-0003-3415-2152
Geraldo R SartoriSão Carlos Institute of Physics, University of São Paulo, São Carlos, São Paulo 13566-590, Brazil.ORCID 0000-0001-5613-7194
João H M SilvaLaboratory of Structural and Functional Biology Applied to Biopharmaceuticals, Fundação Oswaldo Cruz, Fiocruz Ceará, Eusébio 61773-270, Brazil.ORCID 0000-0003-1534-9857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The utilization of predictive tools has become increasingly prevalent in the development of biopharmaceuticals, reducing the time and cost of research. However, most methods for computational antibody design are hampered by their reliance on scarcely available antibody structures, potential for immunogenic modifications, and a restricted exploration of the paratope's potential chemical and conformational space. We propose Ab-SELDON, a modular and easily customizable antibody design pipeline capable of iteratively optimizing an antibody-antigen (Ab-Ag) interaction in five different modification steps, including CDR and framework grafting, and mutagenesis. The optimization process is guided by diversity data collected from millions of publicly available human antibody sequences. This approach enhanced the exploration of the chemical and conformational space of the paratope during computational tests involving the optimization of an anti-HER2 antibody. Optimization of another antibody against Gal-3BP stabilized the Ab-Ag interaction in molecular dynamics simulations at lower runtime than alternative pipelines. Tests with SKEMPI's Ab-Ag mutations also demonstrated the pipeline's ability to correctly identify the effect of the majority of mutations, especially multipoint and those that increased binding affinity. This freely available pipeline presents a new approach for computationally efficient and automated

Indexed as

AntibodiesDrug DesignProtein EngineeringAutomationHumansMolecular Dynamics SimulationProtein ConformationAntibodies

Identifiers

PMID41557947
PMCPMC12892330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.